• ROAR Urges Responsible Antibiotic Use During Get Smart About Antibiotics Week Nov 14-20

    According the U.S. Centers for Disease Control and Prevention, each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die as a direct result of these infections.

    Category: In the News item

  • Vaccine for Zika Virus May Be Years Away, Disease Experts Warn

    As public health officials warn that the Zika virus is swiftly spreading across the Americas, the search is on to develop a vaccine to halt the disease, which could infect as many as four million people by the end of the year and has been linked to severe birth defects.

    Category: In the News item

  • Ebola Returns: 2nd Case of Relapse Raises Questions

    The two cases of probable relapse “tell us that this can happen,” but not how frequently, Goodman said. “It’s likely not to be that common because it hasn’t been described in previous outbreaks,” he said. Goodman stressed that these cases of relapse should not be a reason to cast stigma on Ebola survivors because there have been no documented cases of disease transmission as a result of casual contact with Ebola survivors.

    Category: In the News item

  • How Ebola Vaccine Success Could Reshape Clinical Trial Policy

    Margaret Chan, director-general of the WHO, said on 31 July that the agency is developing a “blueprint” for accelerated development of measures to counteract potential epidemics. The plan aims to reduce the time from the recognition of an outbreak to availability of countermeasures to four months or less, and would include putting trial designs and regulatory approvals in place in advance of an outbreak.

    Category: In the News item

  • Ebola Vaccine Hailed as Game-Changer in Fight Against the Virus

    “I think it is very encouraging to see these very positive, preliminary results of this vaccine trial from Guinea,” says Dr. Jesse Goodman, an infectious disease specialist at Georgetown University, who once led vaccine development at the U.S. Food and Drug Administration.


  • Ebola Leaves Ongoing Health Issues for Survivors of the Viral Disease

    The long-term effects of Ebola have not been well studied, and doctors will probably learn a lot more about the disease’s aftermath from the current outbreak in West Africa, the largest in history, said Jesse Goodman, an infectious-disease expert and a professor of medicine at Georgetown University Medical Center.

    Category: In the News item

  • President Signs Order to Fight Superbugs

    Dr. Jesse Goodman, director of the Center on Medical Product Access, Safety and Stewardship at Georgetown University Medical Center, says antibiotic resistance is one of the most pressing global public health threats. “Success will require a sea change. Doctors, farmers and agribusiness, health systems and the public all need to think totally differently about antibiotics,” Goodman said.

    Category: In the News item